Google Owner Alphabet Launches Ai Driven Startup to Discover New Drugs

Google owner Alphabet has launched an artificial intelligence company to discover new drugs.

UK-registered Isomorphic Labs will use technology from sister company DeepMind to find cures for some of humanity’s most devastating diseases.

AlphaFold2 technology could be used to predict the shape of every protein in the human body with almost perfect accuracy. Its speed could cut the time to discovering innovative treatments, although the process of clinical trials is still likely to take several years.

The company will partner with pharmaceutical and biomedical companies and hopes to use the technology to try to find treatments for Chagas disease and Leishmaniasis, two of the most deadly diseases in the world.

Alphabet is launching a company that uses AI for drug discovery

AI tools could speed the process of finding new drugs

Continue reading on The Verge

AI drug discovery platform Insilico Medicine announces $255 million in Series C funding ? TechCrunch

Insilico Medicine, an AI-based platform for drug development and discovery, announced $255 million in Series C financing on Tuesday. The massive round is reflective of a recent breakthrough for the company: proof that its AI-based platform can create a new target for a disease, develop a bespoke molecule to address it and begin the clinical trial process.

Continue reading on TechCrunch

Code Ocean Selected by Lantern Pharma to Power A.I. Focused Computational Research Environment for Oncology Drug Development

Code Ocean, the leading computational research environment for sharing scientific discoveries, today announced a collaboration that will power AI-driven computational research for oncology-focused drug discovery with Lantern Pharma, a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence (“A.I.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development.

Continue reading on